Investigating the Anabolic Response to Resistance Exercise After Critical Illness (ARTIST-2) (ARTIST-2)
Primary Purpose
Critical Illness, Muscle Loss
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Resistance exercise
Oral protein supplementation
Sponsored by
About this trial
This is an interventional treatment trial for Critical Illness focused on measuring Resistance exercise, Muscle protein, Anabolic resistance
Eligibility Criteria
Inclusion Criteria:
- Adult (≥18 years) previously admitted to an ICU at Karolinska University Hospital for ≥3 days and discharged alive from hospital
OR
- Adult (≥18 years) without a history of ICU admission within the last 30 years
Exclusion Criteria:
- Not able to provide informed consent
- >6 months since ICU discharge*
- Warfarin or dual antiplatelet therapy
- Clinically significant inherited or acquired disorder of hemostasis
- Lower-limb amputee
- Lower-limb atherosclerotic disease with critical ischemia.
- Recent fracture in lower limbs or significant osteoarthritis limiting movement in knee or hip joint
- Metastatic cancer or active hematological malignancy
- Inherited disorder of amino acid metabolism.
- Chronic muscle, neuromuscular or neurologic disease with prior documentation of clinically significant lower-limb involvement
- Pregnancy
- Single organ failure not requiring invasive mechanical ventilation during ICU stay*
Exclusion criteria marked with asterisk only apply to former ICU patients.
Sites / Locations
- Karolinska University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Former ICU patients
Age- and sex-matched control group
Arm Description
Research subjects with a prior history of ICU treatment within six months.
Research subjects without a prior history of ICU treatment within the last 30 years, age- and sex-matched in a 1:2 ratio to the experimental arm.
Outcomes
Primary Outcome Measures
Muscle protein fractional synthetic rate
The difference between the experimental and active comparator group in muscle protein fractional synthetic rate.
Secondary Outcome Measures
Gene expression
The difference between the experimental and active comparator group in gene expression (mRNA) in skeletal muscle, assessed by RNA sequencing.
Signaling pathways
The difference between the experimental and active comparator group in the activity of major anabolic/catabolic signalining pathways in skeletal muscle, assessed by western blot.
Full Information
NCT ID
NCT05261984
First Posted
February 20, 2022
Last Updated
October 23, 2023
Sponsor
Karolinska University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05261984
Brief Title
Investigating the Anabolic Response to Resistance Exercise After Critical Illness (ARTIST-2)
Acronym
ARTIST-2
Official Title
Investigating the Anabolic Response to Resistance Exercise After Critical Illness: The ARTIST-2 Non-Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 8, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
ICU survivors often suffer from long-term functional disability. An attenuated response to physical exercise in skeletal muscle after critical illness may contribute to persisting weakness.
The aim of this study is to investigate the effects of resistance exercise on muscle protein synthesis in former ICU patients. The investigators hypothesize that study subjects recovering from critical illness have an impaired anabolic response to resistance exercise after ICU stay as compared to non-critically ill controls.
Detailed Description
Background
The debilitating impact of critical illness has been recognized for several decades. Disability related to intensive care is now described as a syndrome called ICU-acquired weakness (ICUAW). ICUAW affects up to 70% of ICU patients and is most common with higher illness severity. Patients that develop ICUAW require longer hospitalization and have a higher risk of death. Weakness may persists for several years in ICU survivors. It has significant long-term consequences, and is associated with increased health care costs, delayed return to work, and overall poor quality of life.
Muscle atrophy is a major contributor to ICUAW. Critical illness is associated with a rapid loss of skeletal muscle, induced by catabolic signals from proinflammatory cytokines and hormones. The ability to regain lost muscle mass during convalescence may also be impaired. In a small observational study, muscle atrophy resolved only in a minority of ICU survivors at six months after ICU discharge.
Studies in exercise physiology have demonstrated that resistance training and amino acid ingestion have synergistic effects on muscle protein synthesis in healthy subjects. It is therefore an appealing therapy to reconstitute muscle mass after critical illness. Despite several clinical trials, there is equipoise regarding the efficacy of exercise in improving physical function in-ICU after ICU discharge. These mixed signals are unsurprising given the heterogeneous causes of ICUAW.
Only a few studies in this field have examined muscle architecture or cellular signaling in response to training. However, the gold standard in determining the anabolic response to exercise is to directly measure the effects on protein synthesis and breakdown. There is still no published research using this methodology to assess the effects of exercise interventions in former ICU patients. To understand the role of physical exercise in regaining lost muscle mass, the investigators plan to investigate the anabolic effects to resistance training after critical illness.
Aim and hypothesis
The aim of this study is to determine the anabolic response to resistance exercise after critical illness. The investigators hypothesize that study subjects recovering from critical illness have an impaired anabolic response to resistance exercise after ICU stay as compared to non-critically ill controls.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness, Muscle Loss
Keywords
Resistance exercise, Muscle protein, Anabolic resistance
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Former ICU patients
Arm Type
Experimental
Arm Description
Research subjects with a prior history of ICU treatment within six months.
Arm Title
Age- and sex-matched control group
Arm Type
Active Comparator
Arm Description
Research subjects without a prior history of ICU treatment within the last 30 years, age- and sex-matched in a 1:2 ratio to the experimental arm.
Intervention Type
Procedure
Intervention Name(s)
Resistance exercise
Intervention Description
Knee extensions in flywheel inertia machine in four sets of 10 repetitions.
Intervention Type
Dietary Supplement
Intervention Name(s)
Oral protein supplementation
Intervention Description
24 grams of hydrolyzed whey protein.
Primary Outcome Measure Information:
Title
Muscle protein fractional synthetic rate
Description
The difference between the experimental and active comparator group in muscle protein fractional synthetic rate.
Time Frame
150 minutes post-exercise.
Secondary Outcome Measure Information:
Title
Gene expression
Description
The difference between the experimental and active comparator group in gene expression (mRNA) in skeletal muscle, assessed by RNA sequencing.
Time Frame
150 minutes post-exercise.
Title
Signaling pathways
Description
The difference between the experimental and active comparator group in the activity of major anabolic/catabolic signalining pathways in skeletal muscle, assessed by western blot.
Time Frame
150 minutes post-exercise.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Adult (≥18 years) previously admitted to an ICU at Karolinska University Hospital for ≥3 days and discharged alive from hospital
OR
Adult (≥18 years) without a history of ICU admission (control group)
Exclusion Criteria:
Not able to provide informed consent
>6 months since ICU discharge*
Warfarin or dual antiplatelet therapy
Clinically significant inherited or acquired disorder of hemostasis
Lower-limb amputee
Lower-limb atherosclerotic disease with critical ischemia.
Recent fracture in lower limbs or significant osteoarthritis limiting movement in knee or hip joint
Metastatic cancer or active hematological malignancy
Inherited disorder of amino acid metabolism.
Chronic muscle, neuromuscular or neurologic disease with prior documentation of clinically significant lower-limb involvement
Pregnancy
Single organ failure not requiring invasive mechanical ventilation during ICU stay*
Intubated only for airway protection with no other organ failure(s) during ICU stay*
Planned postoperative care in ICU after elective cardiothoracic surgery*
Exclusion criteria marked with asterisk only apply to former ICU patients.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martin Sundström Rehal, MD PhD
Phone
+48-8-58580000
Email
martin.sundstrom@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Arabella Fischer, MD PhD
Email
arabella.fischer@meduniwien.ac.at
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Sundström Rehal, MD PhD
Organizational Affiliation
Karolinska University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Olav Rooyackers, PhD
Organizational Affiliation
Karolinska University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Karolinska University Hospital
City
Huddinge
State/Province
Stockholm
ZIP/Postal Code
14186
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin Sundström Rehal, MD PhD
Phone
+46-8-58580000
Email
martin.sundstrom@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31431489
Citation
Batt J, Herridge MS, Dos Santos CC. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective. Thorax. 2019 Nov;74(11):1091-1098. doi: 10.1136/thoraxjnl-2016-208312. Epub 2019 Aug 20.
Results Reference
background
PubMed Identifier
21470008
Citation
Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.
Results Reference
background
PubMed Identifier
9712558
Citation
Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg. 1998 Aug;228(2):146-58. doi: 10.1097/00000658-199808000-00002.
Results Reference
background
PubMed Identifier
24108501
Citation
Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, Hopkinson NS, Phadke R, Dew T, Sidhu PS, Velloso C, Seymour J, Agley CC, Selby A, Limb M, Edwards LM, Smith K, Rowlerson A, Rennie MJ, Moxham J, Harridge SD, Hart N, Montgomery HE. Acute skeletal muscle wasting in critical illness. JAMA. 2013 Oct 16;310(15):1591-600. doi: 10.1001/jama.2013.278481. Erratum In: JAMA. 2014 Feb 12;311(6):625. Padhke, Rahul [corrected to Phadke, Rahul].
Results Reference
background
PubMed Identifier
16424140
Citation
Wolfe RR. Skeletal muscle protein metabolism and resistance exercise. J Nutr. 2006 Feb;136(2):525S-528S. doi: 10.1093/jn/136.2.525S.
Results Reference
background
PubMed Identifier
29582429
Citation
Doiron KA, Hoffmann TC, Beller EM. Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit. Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.
Results Reference
background
PubMed Identifier
26098746
Citation
Connolly B, Salisbury L, O'Neill B, Geneen L, Douiri A, Grocott MP, Hart N, Walsh TS, Blackwood B; ERACIP Group. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness. Cochrane Database Syst Rev. 2015 Jun 22;2015(6):CD008632. doi: 10.1002/14651858.CD008632.pub2.
Results Reference
background
PubMed Identifier
30043066
Citation
Fossat G, Baudin F, Courtes L, Bobet S, Dupont A, Bretagnol A, Benzekri-Lefevre D, Kamel T, Muller G, Bercault N, Barbier F, Runge I, Nay MA, Skarzynski M, Mathonnet A, Boulain T. Effect of In-Bed Leg Cycling and Electrical Stimulation of the Quadriceps on Global Muscle Strength in Critically Ill Adults: A Randomized Clinical Trial. JAMA. 2018 Jul 24;320(4):368-378. doi: 10.1001/jama.2018.9592.
Results Reference
background
PubMed Identifier
29957714
Citation
Hickmann CE, Castanares-Zapatero D, Deldicque L, Van den Bergh P, Caty G, Robert A, Roeseler J, Francaux M, Laterre PF. Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial. Crit Care Med. 2018 Sep;46(9):1436-1443. doi: 10.1097/CCM.0000000000003263.
Results Reference
background
Learn more about this trial
Investigating the Anabolic Response to Resistance Exercise After Critical Illness (ARTIST-2)
We'll reach out to this number within 24 hrs